These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1585572)

  • 41. Neuromuscular blocking agents and sedative drugs. Clinical uses and toxic effects in the critical care unit.
    Durbin CG
    Crit Care Clin; 1991 Jul; 7(3):489-506. PubMed ID: 1863878
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tracheal intubation without neuromuscular blocking drugs in children.
    Morton NS
    Paediatr Anaesth; 2009 Mar; 19(3):199-201. PubMed ID: 19236642
    [No Abstract]   [Full Text] [Related]  

  • 43. Neuromuscular Blocking Agents and Neuromuscular Dysfunction Acquired in Critical Illness: A Systematic Review and Meta-Analysis.
    Price DR; Mikkelsen ME; Umscheid CA; Armstrong EJ
    Crit Care Med; 2016 Nov; 44(11):2070-2078. PubMed ID: 27513545
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Perioperative management of patients with neuromuscular disorders].
    Johannsen S; Kranke P; Reiners K; Schuster F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Nov; 44(11-12):748-55; quiz 756. PubMed ID: 19918707
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Problems of the immediate postanaesthesia period.
    Asbury AJ
    Br J Hosp Med; 1981 Feb; 25(2):159, 161-3. PubMed ID: 7214081
    [No Abstract]   [Full Text] [Related]  

  • 46. Recommendations on the use of deep neuromuscular blockade by anaesthesiologists and surgeons. AQUILES (Anestesia QUIrúrgica para Lograr Eficiencia y Seguridad) Consensus.
    Errando-Oyonarte CL; Moreno-Sanz C; Vila-Caral P; Ruiz de Adana-Belbel JC; Vázquez-Alonso E; Ramírez-Rodríguez JM; Veiga-Ruiz G; Guasch-Arévalo E; Lora-Tamayo D'Ocón JI
    Rev Esp Anestesiol Reanim; 2017 Feb; 64(2):95-104. PubMed ID: 27692692
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient.
    Murray MJ; DeBlock H; Erstad B; Gray A; Jacobi J; Jordan C; McGee W; McManus C; Meade M; Nix S; Patterson A; Sands MK; Pino R; Tescher A; Arbour R; Rochwerg B; Murray CF; Mehta S
    Crit Care Med; 2016 Nov; 44(11):2079-2103. PubMed ID: 27755068
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Muscle relaxants suitable for day case surgery.
    Geldner G; Wulf H
    Eur J Anaesthesiol Suppl; 2001; 23():43-6. PubMed ID: 11766246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Anesthesiology alternatives for lobectomy with thoracotomy in a patient with allergy to multiple neuromuscular blockers].
    Granell M; Peña J; Ubeda J; Soriano J; Tatay J; Cantó A; Llorens J
    Rev Esp Anestesiol Reanim; 2003 Mar; 50(3):160-2. PubMed ID: 12708217
    [No Abstract]   [Full Text] [Related]  

  • 50. Adducted vocal cords relieved by neuromuscular blocking drug: a cause of impaired mechanical ventilation when using a laryngeal mask airway: two photographically documented cases.
    Ghimouz A; Lentschener C; Goater P; Borne M; Esteve M
    J Clin Anesth; 2014 Dec; 26(8):668-70. PubMed ID: 25439406
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Residual Neuromuscular Blockade in the Critical Care Setting.
    Stawicki N; Gessner P
    AACN Adv Crit Care; 2018; 29(1):15-24. PubMed ID: 29496709
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Problems of general anesthesia within the framework of daily surgery. 2. Inhalation anesthesia, muscle relaxants, practical course].
    Landauer B
    Fortschr Med; 1981 May; 99(17):629-35. PubMed ID: 7239384
    [No Abstract]   [Full Text] [Related]  

  • 53. Anaphylaxis during anesthesia in Norway: a 6-year single-center follow-up study.
    Harboe T; Guttormsen AB; Irgens A; Dybendal T; Florvaag E
    Anesthesiology; 2005 May; 102(5):897-903. PubMed ID: 15851874
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lambert-Eaton myasthenic syndrome during anesthesia: a report of 37 patients.
    Weingarten TN; Araka CN; Mogensen ME; Sorenson JP; Marienau ME; Watson JC; Sprung J
    J Clin Anesth; 2014 Dec; 26(8):648-53. PubMed ID: 25468580
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Residual neuromuscular block and adverse respiratory events.
    Kopman AF
    Anesth Analg; 2008 Nov; 107(5):1756; author reply 1756. PubMed ID: 18931246
    [No Abstract]   [Full Text] [Related]  

  • 56. Anaphylaxis during anaesthesia.
    Plaud B; Donati F; Debaene B
    Br J Anaesth; 2002 Apr; 88(4):604-5; author reply 605-6. PubMed ID: 12066746
    [No Abstract]   [Full Text] [Related]  

  • 57. Reversal of Pipecuronium-Induced Moderate Neuromuscular Block with Sugammadex in the Presence of a Sevoflurane Anesthetic: A Randomized Trial.
    Tassonyi E; Pongrácz A; Nemes R; Asztalos L; Lengyel S; Fülesdi B
    Anesth Analg; 2015 Aug; 121(2):373-80. PubMed ID: 25923435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The use of dioxonium as a neuromuscular blocking agent.
    Salmenperä M; Tammisto T
    Acta Anaesthesiol Scand; 1980 Oct; 24(5):395-8. PubMed ID: 7468129
    [No Abstract]   [Full Text] [Related]  

  • 59. [What are rules of safety for decurarization?].
    Baurain MJ
    Ann Fr Anesth Reanim; 2000 Sep; 19 Suppl 2():398s-402s. PubMed ID: 11072568
    [No Abstract]   [Full Text] [Related]  

  • 60. Recovery from neuromuscular block and vital function testing.
    Eriksson LI
    Acta Anaesthesiol Belg; 1997; 48(1):45-8. PubMed ID: 9099308
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.